Two new prefilled drug delivery devices - one for chronic diseases and another for vaccination are introduced at Technovation 2015 by BD Medical - Pharmaceutical Systems.
Prefilled drug delivery devices are launched with an aim to reduce medication and dosage errors and improved patient compliance to injectable drugs.
BD Neopak is a single-dose, ready-to-use glass prefillable syringe system. It is an advanced version of normal prefillable syringe, which offers additional benefits of prefillable syringe system such as lesser injection time, lessor errors, reduced contamination and much better productivity to patients and clinicians.
BD Uniject SCF (Sterile, Clean and ready to Fill) is a single-use prefilled auto disable injection system that protects against inappropriate needle reuse. It is a tamper roof system, which can be used by healthcare workers for great coverage of outreach programs such as mass immunization.
Both forms of drug delivery system assist in the process of administering pharmaceutical compounds to achieve desired effect far more quickly and effectively.
"In the current environment, patients demand higher quality and more reliability in injectable drug delivery systems. Therefore there is an urgent need to be able to collaborate with industry leaders and introduce cutting edge solutions that will greatly benefit Indian patients. BD as a technology and innovation driven organization has been prudent to respond to evolving needs and provide great value to customers," said Murli Sundrani, Business Director, BD Medical-Pharmaceutical Systems, BD India.
Increasing incidence of chronic diseases such as autoimmune diseases, diabetes and cancer are driving the growth of self-administration of drug.
Currently prefilled drug delivery systems are considered to be the preferred mode of administering more than 50 injectable drugs.
The risk of contamination and dosage error can be eliminated while using prefillable syringes. It is less time consuming and convenient for doctors, physicians and healthcare workers to use.
Dr S.G. Kasi, Principal Investigator, Time & Motion Study said, "This is a first kind of study done in India which demonstrates the superiority of prefillables (PFS) over single and multi-dose vials in terms of time taken for one vaccination, vaccine wastage, and errors occurring during vaccination. The advantages of the PFS have been acknowledged by the CDC, which now recommends it as the "preferred" system of vaccine administration."